Chad Landmon, Esq.
Chairs the FDA and IP practice groups
Axinn, Veltrop & Harkrider LLP
Chad Landmon, Esq. chairs the FDA and IP practice groups at Axinn, Veltrop & Harkrider LLP. He has extensive experience assisting pharmaceutical companies with bringing their products to market, including navigating the complex drug approval pathway at FDA. Mr. Landmon’s experience with FDA matters also includes litigation and advocacy surrounding generic drug marketing exclusivities and application approval standards.
Neema Kumar, Esq.
Senior IP Counsel
Hikma Pharmaceuticals USA Inc.
Neema Kumar, Esq. is Senior IP Counsel at Hikma Pharmaceuticals USA Inc., a New Jersey-based pharmaceutical company that develops, manufactures and markets a broad range of branded, injectable and non-injectable medicines across the U.S., MENA region and Europe. She is responsible for all U.S. intellectual property matters, including patent litigation, counseling and prosecution. Prior to joining Hikma, Ms. Kumar worked at the law firm of Winston & Strawn LLP advising pharmaceutical clients on patent litigation, counseling and diligence issues.